The Ozempic and Wegovy mistake sending thousands to poison control
Researchers are investigating a significant rise in poison control center calls related to semaglutide, the active ingredient in weight-loss drugs like Ozempic and Wegovy. The study suggests that the surge in calls may be linked to the drug's rapid popularity and potential misuse following its FDA approval for weight management.
Why it matters
Understanding the causes behind the spike in poison control calls is critical for public safety as GLP-1 receptor agonists become increasingly common for weight management.
The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers' attention: a dramatic increase in calls to poison control centers across the United States.
The article reports on academic research findings without taking a political stance or using loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in